Study of tiny cancer spread found in sentinel lymph nodes
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies whether very small deposits of cancer (called micrometastasis or isolated tumor cells) are found in sentinel lymph nodes in early endometrial or cervical cancer. The goal is to better understand what these findings may mean for cancer spread and treatment planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage endometrial cancer and are scheduled for a sentinel lymph node (SLN) procedure
- You have early-stage cervical cancer and are scheduled for a sentinel lymph node (SLN) procedure
- Your sentinel lymph nodes will be checked using special detailed testing (either standard ultra-staging or a one-step tumor-DNA test called OSNA)
- Your sentinel lymph node testing shows cancer spread that is either large (macrometastasis) or small/low volume (micrometastasis or isolated tumor cells)
- You have not had another cancer within the last 5 years, except for non-melanoma skin cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses tumor tissue and genetic test results to understand which features predict whether lymph nodes (sentinel nodes) are cancer-positive in endometrial (uterine) cancer. It mainly helps doctors improve how they predict spread and tailor care.
This trial compares a fast lab test (OSNA) with standard microscope checks to see which better finds cancer in the first lymph node (sentinel node) during surgery for early-stage endometrial cancer. It aims to improve accuracy and speed while avoiding unnecessary lymph node removal.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This trial studies how to find the “sentinel” (first) lymph node during surgery for high-risk endometrial (uterine) cancer. It may help surgeons better tell whether cancer has spread to nearby lymph nodes and guide the extent of lymph node removal.
This trial tests a “sentinel node” biopsy, using a special dye/tracer, during surgery for early-stage endometrial cancer. It may help doctors find whether cancer has spread to lymph nodes while possibly avoiding more extensive lymph node removal.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.